Century Therapeutics, Inc. (IPSC)

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Allogeneic Cell Therapies	6.59M	Log In	Log In
Allogeneic Cell Therapies Growth	194.81%	Log In	Log In

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
United States	6.59M	Log In	Log In
United States Growth	194.81%	Log In	Log In